Pfizer Inc., the American multinational pharmaceutical and biotechnology corporation has seen its sales double in the fourth quarter.
With the global demand for the COVID-19 vaccine, the company continues to ride the wave in sales.
According to press reports, the company posted revenue of $23.8 billion, albeit missing analysts’ projections of $24.1 billion.
The company’s vaccine unit accounted for $13.9 billion, more than half of its total sales.
The company also reported a net income of $3.4 billion, topping analysts’ forecasts.
Pfizer said it expects $32 billion in sales this year from the COVID-19 vaccine, Comirnaty.
Readers Bureau, Contributor
Edited by Jesus Chan
Do you want to add feedback to this story?